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The presence of hypoxic cells within tumours has a negative
impact on several different cancer treatment modalities. In addi-
tion to being a well-established cause of resistance to radiation
therapy (Thomlinson and Gray, 1955), hypoxia has been shown to
have an adverse effect on the in vitro cytotoxic activity of photo-
dynamic therapy (Chapman et al, 1991) and various chemothera-
peutic agents, including tumour necrosis factor-a (Sampson and
Chaplin, 1994) and adriamycin (Smith et al, 1980). Clinically
hypoxic areas have been shown to exist in human tumours and are
known to influence patient survival and treatment outcome
(Höckel et al, 1993, 1996; Brizel et al, 1996; Nordsmark et al,
1996; Overgaard and Horsman, 1996).
Because of the relative resistance of hypoxic cells to different
treatment modalities, and the importance of hypoxia in treatment
outcome, much effort has been directed towards overcoming
tumour hypoxia. A common current approach has been the
breathing of hyperoxic gases, including 100% oxygen (O2) and
carbogen (95% O2 and 5% CO2). The rationale for the use of
carbogen over 100% O2 is based on the following putative
mechanisms: (1) CO2 blocks hyperoxia-induced vasoconstriction,
(2) increased CO2 tensions cause a rightward shift of the
oxygen–haemoglobin dissociation curve and (3) CO2 has a posi-
tive chronotropic effect (Kruuv et al, 1966). Despite these sound
theoretical grounds, the inhalation of carbogen has had only
moderate success as a radiosensitizer (Siemann et al, 1977;
Overgaard, 1989; Rojas, 1991). Although breathing of oxic gases
such as carbogen clearly increases the total oxygen content of
blood, there may be other complex physiologic interactions which
affect the ability of this gas to increase pO2 in solid tumours.
It has long been known that carbogen can inhibit hyperoxia-
induced vasoconstriction or even increase blood flow in some
tissues, particularly neural tissue like the brain (Kety and Schmidt,
1948) and retina (e.g. Hickam and Frayser, 1966) but there is
evidence that carbogen decreases flow in some other tissues
(Hampson et al, 1987; Honess and Bleehen, 1995). Furthermore,
the vasoactive effects of carbogen appear to be dependent on
route of administration, with mechanically ventilated animals
responding with vasodilation, and freely breathing animals with
vasoconstriction (Kallinen et al, 1991). In addition, recent work
has demonstrated that carbogen may induce vasoconstriction in
both normal and tumour arterioles (Dewhirst et al, 1996), and can
cause simultaneous increases and decreases in both blood flow and
pO2 within the same tumours (Powell et al, 1996; Lanzen et al,
1998). Alternatively, a consistent decrease in blood flow was
found in subcutaneously implanted sarcoma F tumours in mice
during carbogen breathing (Hill et al, 1998). These findings all
argue against the proposed mechanism of action of carbogen, at
least in some tumours.
Falk and associates (1992) demonstrated that the time course
over which carbogen is given significantly impacts its ability to
increase oxygenation in tumours. Siemann and co-workers (1977)
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direct impact on the outcome of radiation treatment. This phenom-
enon may be attributable to time-dependent alterations in tumour
blood flow (TBF) or it may be partially due to increases in oxygen
consumption induced by the use of oxic gases (Dewhirst et al,
1996). Before carbogen can be optimally used as a radiosensitizer,
it will be necessary to understand the mechanisms responsible for
these complex and variable effects on tumour blood flow and
oxygenation.
In a recent study we found that the arterioles of normal tissues
and tumours growing in rat dorsal flap window chambers exhib-
ited no vasoconstriction during 100% O2 breathing (Dewhirst et al,
1996). In addition, we found that carbogen breathing tended to
cause an initial transient vasoconstriction in both tumour and
normal arterioles, although this change was not consistently statis-
tically significant with the small numbers of animals studied.
These surprising results inspired us to investigate the effects of
hyperoxic and hypercarbic gases in greater detail. We hypothe-
sized that the presence of CO2 in the breathing gas might have
vasoconstrictive effects in this model system, and that the level of
CO2 in the breathing gas might be directly correlated to the degree
of vasoconstriction of the tumour arterioles. In this present study,
we performed experiments investigating the effect of breathing
gases containing 1% CO2, 5% CO2, or 10% CO2 mixed with
oxygen on arteriolar diameter and blood flow in R3230Ac
mammary adenocarcinomas growing in the dorsal flap window
chamber in Fischer 344 rats.
MATERIALS AND METHODS
Animal model
Fischer 344 rats (Charles River Laboratories, Raleigh, NC, USA)
were surgically implanted with cutaneous window chambers as
described previously (Papenfuss et al, 1979). R3230Ac mammary
adenocarcinomas were transplanted onto a fascial plain of sub-
cutaneous tissue at the time of window chamber surgery. Prior to
experimentation, the animals were housed individually in an
environmental chamber maintained at 34°C and 50% humidity
with continuous access to food and water. Experimentation was
performed 9–11 days following transplantation. All protocols were
approved by the Duke Animal Care and Use Committee.
Anaesthesia and blood gases
Animals were anaesthetized with sodium pentobarbital (50 mg
kg-1  intraperitoneally (i.p.)) for all surgical and experimental
procedures. Heart rate (HR) and blood pressure were obtained
from computerized acquisition (AT-codas, Dataq Instruments,
Akron, OH, USA) of femoral arterial waveforms. Blood gas
measurements were obtained from 0.2 ml samples of femoral arte-
rial blood. During experimentation, animals were maintained at a
rectal temperature of 36–37°C using a thermostatically controlled
blanket (Model 50-7503 Homeothermic Blanket, Harvard
Bioscience, N. Natick, MA, USA).
Videomicroscopy
Videomicroscopy of window chamber microvasculature was
performed in order to directly observe tumour arterioles during
experimentation (Zeiss Photomicroscope III, Carl Zeiss, New
York, NY, USA). Window chamber arterioles were visualized at
200´ using transillumination with either a 40 W tungsten source or
mercury lamp (HBO-50W, Carl Zeiss, New York, NY, USA),
depending on the thickness of the window chamber preparation.
Images were acquired using a CCD camera (MTI CCD-72, Dage-
MTI, Michigan City, MI, USA) and recorded on VHS videotape
(SVO-9500 MD, Sony Corporation of America, San Jose, CA,
USA). A videotimer image (CTG-55 Video Timer, ForA Co., Los
Angeles, CA, USA) was superimposed on all video tapes for
subsequent analysis of arteriolar diameter.
Experimental protocols
Anaesthetized rats with window chambers were placed in right
lateral recumbency position on the microscope stage. Following
identification of the tumour feeding arterioles as described below, a
laser Doppler probe was positioned beneath the stage (see below).
A face mask was used to administer the various gases to the animal.
Measurements of blood pressure, heart rate, laser Doppler flow,
and arteriolar diameter were taken every 30 s for the duration of
the experiment. Baseline values under conditions of room air
breathing were collected for a period of 20 min. The animals were
then exposed to one of three different O2–CO2 gas mixtures for a
period of 40 min. The three gas mixtures were 1% CO2–99% O2,
5% CO2–95% O2 (carbogen) and 10% CO2–90% O2. A baseline
arterial blood gas sample under room air conditions was collected
prior to the beginning of recording. A second sample was collected
during exposure to the hypercarbic–hyperoxic gas at the end of
experimentation.
A total of 28 rats were used in this study. Nine were exposed to
1% CO2–99% O2, ten were given 5% CO2–95% O2 and nine
breathed 10% CO2–90% O2.
Arteriolar diameter measurements
Tumour feeding arterioles within the subcutaneous (s.c.) vascular
bed beneath the tumour were identified. The following criteria
were used in defining a tumour feeding arteriole in this model
system: (1) observable divergent flow; (2) straight vessel wall,
with birefringence associated with the intimal layer; (3) the vessels
had to be directly connected to microvessels that enter the tumour
mass (Dewhirst et al, 1994). Arteriolar diameters were measured
at 30 s intervals using an image shearing monitor (Model 907,
IPM Inc., La Jolla, CA, USA) as described previously (Dewhirst et
al, 1989).
Arteriolar diameter measurements are presented as relative data,
normalized to the vessel diameter at the beginning of the experi-
ment, i.e. time zero. The baseline diameters are presented as the
average diameter during air breathing, i.e. from 0 to 20 min.
Laser Doppler flowmetry
A single channel laser Doppler flowmeter (LaserFlow BPM 403A,
TSI Inc., St. Paul, MN, USA) was used for evaluation of changes
in tumour perfusion. The probe was connected to a microcomputer
(Zenith Data Systems, model 2BV-3339-KQ, Benton Harbor, MI,
USA) equipped with data acquisition software interfaced to digital
I/O Analog output (DATAQ model DI-40). The probe was
attached to the microscope stage in a fixed position, with the tip
located approximately 1–2 mm beneath the window chamber
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absolute flow, the resultant data are reported as relative blood flow
values, normalized to the flow at the beginning of the experiment,
i.e. time zero. Measurements were taken every 30 s.
Statistical methods
All experimental data were compared non-parametrically. The
Wilcoxon signed-rank test was used to determine if values at any
given time point were different from the baseline value (value at
time zero). Differences in baseline parameters among the treat-
ment groups were compared using the Wilcoxon rank-sum test or
the Kruskall–Wallis test. All quoted P-values are two-sided, and
significance is assumed if P < 0.05.
Mathematical modelling method
The model used to analyse the effects of changes in tumour blood
flow and oxygen consumption on the hypoxic fraction in tumours
has been described in detail elsewhere (Secomb et al, 1995).
Briefly, a Green’s function method was used to calculate the distri-
bution of oxygen tension in a region of tumour tissue containing a
three-dimensional network of microvessels. The network was
based on vascular architecture observed in an actual tumour
growing in the dorsal flap window chamber model. The region is
relatively small and does not represent the entire pathway for
blood flow through a tumour. In order to include the effects of
oxygen extraction from blood before it reaches the region that is
simulated, we assumed that the arterial blood passed through an
upstream oxygen-consuming region.
Control state values of necessary model parameters were chosen
based on previous experimental observations in this preparation:
arterial blood pO2 = 100 mmHg, pO2 of blood entering the simula-
tion volume = 40 mmHg, and blood flow rate = 8 ´ 10–7 ml s-1. The
oxygen consumption rate was set to 2.4 ml O2 100 g-1 min-1. By
knowing these parameters, the distribution of pO2 within the tissue
block was determined, and the hypoxic fraction (percentage of
tissue with pO2 < 3 mmHg) was calculated.
The parameters used for the carbogen breathing state were also
based on previous experimental observations in this preparation
(Dewhirst et al, 1996): arterial blood pO2 = 450 mmHg, pO2 of
blood entering simulation volume = 80 mmHg.
In the present study this model was used to determine the
balance between CO2-induced changes in blood flow and
increased vascular pO2 on the hypoxic fraction. For demonstration
purposes, only those changes induced by carbogen breathing are
presented.
RESULTS
Blood gases
The arterial oxygen tension (PaO2) for 25 of the 28 experiments
under air breathing conditions averaged 93 ± 3 mmHg (mean ±
s.e.m.). The arterial CO2 tension (PaCO2) was 47.6 ± 1.0 mmHg,
and the pH was 7.362 ± 0.009. Blood gas values during air
breathing were not available in three rats, but the post-experi-
ment blood gas samples verified that these animals received the
hyperoxic–hypercarbic gases. There was some variability among
the baseline values for the individual groups (Table 1), but most
values were in the range of those seen in unanaesthetized rats
(Libermann et al, 1973). The slightly high arterial pCO2 is typical
for rats anaesthetized with this dose of pentobarbital (Libermann
et al, 1973). The arterial pO2 and pH values were significantly
different among the three air-breathing groups (P < 0.03,
Kruskal–Wallis test). In particular, the air-breathing rats in the 5%
CO2 group were more acidotic and had higher arterial pO2s than
the other two groups (Table 1).
Changing the breathing gas from air to 1% CO2–99% O2
predictably resulted in a significant increase in PaO2 and a small
significant decrease in pH (Wilcoxon signed-rank test, P < 0.02),
but PaCO2 was not altered (Table 1). Switching the breathing gas
from air to either 5% CO2–95% O2 or 10% CO2–90% O2 resulted
in significant changes in all three parameters (Table 1). As might
be expected, arterial pH decreased, while PaO2 and PaCO2 signifi-
cantly increased (P < 0.02).
All three arterial blood gas parameters tended to change as the
composition of the O2–CO2 gas mixtures was altered, although only
the values during 1% CO2 breathing were statistically different
compared to either the 5% CO2 or the 10% CO2 data (Wilcoxon
rank-sum test, P < 0.05; Table 1). As the CO2 content increased and
the O2 content decreased, the pH and PaO2 decreased and the PaCO2
increased. The parameters measured during 5% CO2 breathing
were not different from those obtained during 10% CO2 breathing.
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Table 1 Arterial blood gases and arteriolar diameters (Mean (s.e.m.))
Treatment pH PaO2 PaCO2 Diameter
group n (mmHg) (mmHg) (mm)
Room air 7.386 (0.002) 90 (2) 47.8 (0.4) 62.7 (6.7)
1% CO2 9 7.368 (0.005)a 494 (9)a 48.6 (1.1)
Room air 7.320 (0.019) 103 (5) 45.2 (2.8) 48.5 (13.2)c
5% CO2 8 7.227 (0.036)a,b 437 (23)a,b 65.1 (6.1)a,b
Room air 7.376 (0.006) 85 (3) 49.9 (0.7) 77.7 (13.6)d
10% CO2 8 7.231 (0.006)a,b 411 (5)a,b 73.2 (2.7)a,b
aDenotes a significant difference (P < 0.04) between value and corresponding room air value (Wilcoxon signed-rank test). bDenotes a
significant difference (P < 0.05) between value and 1% CO2 value (Wilcoxon rank-sum test). cn = 10; dn = 9.Mean arterial pressure
Arterial blood pressures during air breathing were within normal
limits for unanaesthetized rats, averaging 113 ± 2 mmHg (Smith et
al, 1987). There were no significant pre-treatment differences in
mean arterial pressure (MAP) among the three groups of animals
(P = 0.46; Kruskal–Wallis test).
Effects of gas administration on mean arterial pressure are
shown in Figure 1A. Animals exposed to 1% CO2 experienced an
immediate 5% increase in MAP (P = 0.04) that gradually
increased to 10% after 20 min of gas administration and remained
elevated for the duration of gas exposure (P = 0.04). After an
initial immediate increase in blood pressure of approximately 7%
(P < 0.02), animals exposed to 5% CO2 experienced a sharp and
sustained return to baseline values 3 min after gas administration.
The effects of administration of 10% CO2 on MAP are shown in
Figure 1A and separately in Figure 1B, along with standard errors
of the mean. Animals exposed to 10% CO2 experienced a gradual
decrease in MAP to almost 90% of baseline (P < 0.03) 5 min after
gas administration. Blood pressure remained at 90% of baseline
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Figure 1 Effects of breathing of hyperoxic–hypercarbic gas mixtures on
relative mean arterial blood pressure (MAP) in the rat. (A) Rats were breath-
ing air from 0 to 20 minutes, followed by either 1% CO2–99% O2 (n = 9), 5%
CO2–95% O2 (n = 10), or 10% CO2–90% O2 (n = 9) for the next 40 min. All
values are relative to the MAP at 0 min and the plots are the means of n rats.
(B) Effect of 10% CO2–90% O2 breathing (n = 9) on mean relative MAP with
error bars demonstrating the standard error of the mean (s.e.m.)
Figure 2 Effects of breathing of hyperoxic–hypercarbic gas mixtures on
relative heart rate in the rat. (A) Rats were breathing air from 0 to 20 min,
followed by either 1% CO2–99% O2 (n = 9), 5% CO2–95% O2 (n = 10), or
10% CO2–90% O2 (n = 9) for the next 40 min. All values are relative to the
heart rate at 0 min and the plots are the means of n rats. (B) Effect of 10%
CO2–90% O2 breathing (n = 9) on mean relative heart rate with error bars
demonstrating the standard error of the mean (s.e.m.).values for approximately 20 min after the start of 10% CO2
breathing (P < 0.05) before gradually returning to baseline levels
after 40 min.
Heart rate
Baseline parameters for HR were within normal limits for
unanaesthetized rats, averaging 346 ± 7 beats per min (Smith et al,
1987). There were no significant pre-treatment differences in heart
rate between the three groups of animals (P = 0.35).
Effects of hyperoxic/hypercarbic gas administration on HR are
shown in Figure 2A. Animals exposed to 1% CO2 experienced no
significant change in HR for the duration of gas administration.
Administration of 5% CO2 resulted in a trend towards an initial
decrease of 3% immediately after gas exposure (P = 0.09),
followed by a gradual decrease of 8% at 20 min of exposure
(P < 0.04) that was sustained throughout the duration of carbogen
breathing. The effects of 10% CO2 on heart rate are shown in
Figure 2B, along with standard errors of the mean. Administration
of 10% CO2 produced no significant change in heart rate, although
an initial decrease of 5% occurred immediately after gas adminis-
tration and was of borderline statistical significance (P = 0.06).
Arteriolar diameter
Mean baseline arteriolar diameters during air breathing (averaged
over 0–20 min) were 63, 49 and 78 mm for the 1%, 5% and 10%
CO2 experimental groups respectively (Table 1). Although the
baseline diameters were quite variable, the values in the three
different dose groups did not differ significantly from each other
(P > 0.05).
Vasoconstriction was observed within seconds of
hyperoxic/hypercarbic gas administration in all three dose groups
(Figure 3A), although the statistical significance of sustained
reduction in arteriolar diameter was variable. Administration of
1% CO2 produced a maximal reduction in arteriolar diameter of
approximately 10% 2 min after exposure (P = 0.008). Carbon
dioxide-induced vasoconstriction remained statistically significant
for approximately 8 min after the beginning of 1% CO2–99% O2
breathing (P < 0.05). Thereafter, the diameter was not statistically
different from baseline.
Administration of 5% CO2 produced a maximal reduction in
arteriolar diameter of approximately 20% 4 min after gas exposure
(P < 0.005). The diameter returned to about 85% of baseline after
12 min (P = 0.08), and this reduction in arteriolar diameter
was sustained throughout the duration of carbogen breathing
(P < 0.05).
The effects of 10% CO2 on arteriolar diameter, along with stan-
dard errors of the mean are shown in Figure 3B. Administration of
10% CO2 produced an immediate reduction in arteriolar diameter
of approximately 23% (P = 0.004), followed by a partial recovery
toward baseline. The diameter returned to more than 90% of base-
line 8 min after exposure. The vasoconstriction produced by CO2
at this dose was significant only for the first 4 min of gas exposure.
Tumour blood flow
Relative changes in TBF as assessed by laser Doppler flowmetry
are shown in Figure 4A. Administration of 1% CO2 produced no
statistically significant change in blood flow. Breathing of 5% CO2
resulted in an immediate and significant drop to approximately
65% of baseline flow after 3–4 min of gas exposure (P = 0.004).
Reduction in blood flow was sustained at 70–75% of baseline flow
for the duration of gas exposure, with 67 of 80 time points being
statistically significant (P < 0.05). The effects of 10% CO2 on TBF
along with standard errors of the mean are shown in Figure 4B.
Administration of 10% CO2 produced an immediate reduction to
65% of baseline blood flow after 2 min of gas exposure (P < 0.02).
The blood flow quickly tended back toward the baseline value, and
by 4 min after the beginning of 10% CO2 breathing, the flow was
not significantly different from baseline.
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Figure 3 Effects of breathing of hyperoxic–hypercarbic gas mixtures on
relative arteriolar diameter in the rat. (A) Rats were breathing air from 0 to
20 min, followed by either 1% CO2–99% O2 (n = 9), 5% CO2–95% O2
(n = 10), or 10% CO2–90% O2 (n = 9) for the next 40 min. All values are
relative to the diameter at 0 min and the plots are the means of n rats.
(B) Effect of 10% CO2–90% O2 breathing (n = 9) on mean relative arteriolar
diameter with error bars demonstrating the standard error of the mean
(s.e.m.)DISCUSSION
In this study we have altered the CO2 component of an inspired
hyperoxic gas in an attempt to understand and confirm previously
observed changes in tumour arteriolar diameter (TAD) and TBF in
the rat dorsal window chamber model. By using three different
O2–CO2 mixtures, we tested the hypothesis that the presence of
carbon dioxide in hyperoxic gases has vasoconstrictive activity in
this tumour model. The effects of the three gases studied are
summarized in Table 2. Breathing 1% CO2–99% O2 increased
MAP and caused a transient tumour arteriolar vasoconstriction,
but exerted no significant chronotropic or blood flow effects.
Carbogen (5% CO2–95% O2) transiently increased MAP,
decreased HR and vasoconstricted tumour arterioles, resulting in a
sustained decrease in TBF. Breathing of 10% CO2–90% O2 caused
a slight reduction in MAP but no change in HR, while transiently
vasoconstricting tumour arterioles and decreasing TBF.
Effects of different O2–CO2 breathing mixtures on MAP
and HR
The effects of the CO2 content of the breathing gases on blood
pressure and HR are in general agreement with those found previ-
ously in rats (Lioy and Trzebski, 1984). Breathing 1% or 5% CO2
resulted in a sustained or transient pressor response (Figure 1). On
the other hand, MAP decreased transiently when the rats breathed
10% CO2–90% O2, which may indicate that this concentration of
CO2 might be sufficient to cause enough direct dilatory action of
CO2 on the systemic resistance vessels to dominate the response
(Lioy and Trzebski, 1984). Although there was a trend for heart
rate to decrease during breathing of all three hyperoxic–hyper-
capnic gas mixtures, the only significant change occurred during
carbogen breathing, when heart rate decreased by about 8%. The
CO2-induced bradycardia is most likely the result of direct action
of CO2 on the heart (Lioy and Trzebski, 1984).
Effects of different O2–CO2 breathing mixtures on TAD
and TBF
As shown in Figure 3, there was a clear decrease in TAD following
breathing of all hypercarbic gases. In the first minutes following
the initiation of hyperoxic–hypercarbic gas breathing, the arteri-
olar diameter dropped significantly. There was no clear
dose–response, although 1% CO2–99% O2 only caused a transient
10% vasoconstriction, while the initial vasoconstriction was
around 20–25% after administration of the gases containing 5%
CO2 or 10% CO2. To our knowledge, there is no other data avail-
able on the effects of breathing hyperoxic-hypercarbic gases on
TAD, except for the limited data from our laboratory involving the
effects of carbogen breathing (Dewhirst et al, 1996). The large
decrease in arteriolar diameter seen during carbogen breathing was
not evident in the earlier limited study, in which experiments were
performed in only five rats, and there was a transient, but statisti-
cally insignificant, decrease in arteriolar diameter of about 10%. In
re-examining those data, the mean arterial pCO2 in those experi-
ments changed only from 46 to 50 mmHg after initiation of
carbogen breathing, while in this study the corresponding change
was from 44 to 62 mmHg. Therefore, the more significant vaso-
constriction observed in the current study may be attributable to
better delivery of carbogen to the rats in this study. One question
that needs to be addressed is whether the changes in TAD were the
passive result of a vascular steal phenomenon or whether they
were an active response to the higher CO2 content of the blood. In
our prior study in this model system we found that normal arteri-
oles constricted to the same degree as tumour arterioles in
response to carbogen breathing (Dewhirst et al, 1996). This argues
against a vascular steal phenomenon as being responsible for the
observed effects.
The changes in TBF caused by the breathing of hypercarbic
gases tended to approximately mirror the changes in TAD, as
shown in Figures 3 and 4. The small, transient decrease in arteriolar
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Figure 4 Effects of breathing of hyperoxic–hypercarbic gas mixtures on
relative laser Doppler blood flow (LDF) in the rat. (A) Rats were breathing air
from 0 to 20 min, followed by either 1% CO2–99% O2 (n = 9), 5% CO2–95%
O2 (n = 10), or 10% CO2–90% O2 (n = 7) for the next 40 min. All values are
relative to the LDF at 0 min and the plots are the means of n rats. (B) Effect
of 10% CO2–90% O2 breathing (n = 7) on mean relative LDF with error bars
demonstrating the standard error of the mean (s.e.m.)diameter following initiation of 1% CO2–99% O2 breathing resulted
in no significant change in TBF. On the other hand, the large initial
vasoconstriction caused by breathing hyperoxic gases containing
5% or 10% CO2 was accompanied by a 20–30% decrease in TBF.
In addition, the general trend of the recovery of the blood flow
towards baseline during the breathing of these hypercarbic gases
was similar to the recovery of arteriolar diameter.
Our results showing a consistent decrease in TBF during inhala-
tion of hypercarbic gases agrees in general with the findings of
Hill and co-workers (1998), who performed similar experiments in
solid subcutaneously implanted sarcoma F tumours in mice. They
found that any hyperoxic gas containing at least 2.5% CO2 caused
a decrease in TBF.
In contrast to the present results, other studies have shown
either an increase or no change in TBF during breathing of hyper-
oxic–hypercarbic gases. Using the C3HBA mammary carcinoma
implanted subcutaneously in mice as a tumour model, Kruuv et al
(1966) showed that carbogen breathing resulted in a 20% increase
in TBF compared to air breathing. Allowing the mice to breathe
10% CO2–90% O2 caused blood flow to increase by an average of
50% (Kruuv et al, 1966). Similarly, it was recently shown that
carbogen breathing for 6 min resulted in a 50–70% increase in
blood flow in RIF-1 tumours growing subcutaneously in mice
(Honess and Bleehen, 1995). In another study, Grau and co-
workers could show no carbogen-induced change in blood
flow in C3H mammary carcinoma growing in the feet of mice
(Grau et al, 1992). The discrepancy between these data and our
current results may be due to tumour- or site-specific differences in
the vasculature.
There is also a pertinent study in human patients, which exam-
ined the effects of carbogen breathing on TBF using laser Doppler
technology (Powell et al, 1996). In Powell et al’s study, carbogen
breathing resulted in no net change in average blood flow, although
there were carbogen-induced increases and decreases in TBF
within the same tumour or in different tumours. In a recent study,
we have examined the kinetic effects of carbogen breathing on TBF
and pO2 in s.c. R3230Ac tumours growing in the hindlimb and in
muscle sites (Lanzen et al, 1998). In the s.c. site, we observed
simultaneous increases and decreases in blood flow within indi-
vidual tumours, yet tumour oxygenation was unaffected in most
cases. In contrast, when this same tumour line was transplanted into
muscle, consistent improvements in oxygenation were observed,
yet the effects on blood flow were still variable. These results all
suggest that the vasoactive effects of carbogen and other hyper-
oxic–hypercarbic gases are complex and may be dependent upon
animal model, tumour type, site of implantation or other factors.
Finally, it is interesting to compare our results directly with
those of Hill and co-workers who made similar measurements
of blood flow in a solid mouse tumour model during
hyperoxic–hypercarbic gas breathing (Hill et al, 1998). Although
they also found that TBF decreased during breathing of hyperoxic
gas mixtures containing 5% or 10% CO2, the decrease in blood
flow followed a different time course. While blood flow in the
tumour growing in the window chamber decreased almost imme-
diately (Figure 4), blood flow in the solid mouse tumour did not
significantly decrease until 30–45 min after the start of breathing
the hyperoxic/hypercarbic gas. The difference in the time course of
the TBF decrease may possibly be related to the mechanism
behind the change. In the present study, the change in blood flow
closely follows the decrease in the diameter of the tumour feeding
arteriole (Figures 3 and 4), suggesting that a CO2-induced vaso-
constriction is directly responsible for the decrease in TBF. It has
been shown that CO2 can directly affect production of the vaso-
active substances nitric oxide and endothelin-1, but an increase in
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Table 2 Summary of the effects of breathing of hyperoxic–hypercarbic gas mixtures on relative mean arterial blood pressure (MAP),
relative heart rate (HR), relative arteriolar diameter (Diameter), and relative laser Doppler blood flow (LDF) in the rat. All values are
relative to the values at 0 min and are expressed as means (s.e.m.)
Time after start of 1% CO2 breathing
Parameter n 02 5 3 0
MAP 9 1.009 (0.028) 1.091 (0.035)b 1.053 (0.029) 1.136 (0.040)b
HR 9 1.016 (0.019) 0.996 (0.023) 1.005 (0.025) 1.049 (0.041)
Diameter 9 0.990 (0.026) 0.887 (0.054)a 0.922 (0.027)b 0.984 (0.034)
LDF 9 1.002 (0.087) 0.939 (0.128) 0.865 (0.117) 1.138 (0.127)
Time after start of 5% CO2 breathing
Parameter n 025 3 0
MAP 10 1.011 (0.015) 1.057 (0.017)b 1.016 (0.017) 0.989 (0.018)
HR 10 1.009 (0.013) 0.976 (0.013) 0.975 (0.018) 0.920 (0.030)a
Diameter 10 1.009 (0.036) 0.828 (0.061)a 0.814 (0.055)a 0.855 (0.038)b
LDF 10 0.914 (0.079) 0.724 (0.071)a 0.698 (0.069)a 0.726 (0.102)b
Time after start of 10% CO2 breathing
Parameter n 025 3 0
MAP 9 0.958 (0.023) 1.005 (0.036) 0.933 (0.018)b 0.958 (0.017)
HR 9 1.002 (0.022) 0.965 (0.025) 0.966 (0.050) 1.036 (0.029)
Diameter 9 1.029 (0.065) 0.756 (0.052)a 0.860 (0.074) 0.942 (0.079)
LDF 7 1.040 (0.029) 0.698 (0.032)b 0.844 (0.131) 0.901 (0.120)
aDenotes a significant difference between that value and the corresponding baseline value during air breathing at the P < 0.01 level based
on the Wilcoxon signed-rank test. bDenotes a significant difference between that value and the corresponding baseline value during air
breathing at the P < 0.05 level based on the Wilcoxon signed-rank test.local CO2 concentration tends to lead to an increase in nitric oxide
production, a decrease in endothelin-1 production and an endothe-
lium-dependent vasodilation in most vasculature (Yoshimoto et al,
1991; Iadecola, 1992; Carr et al, 1993). Therefore, this effect of
CO2 could not account for the CO2-induced vasoconstriction seen
here. One reasonable explanation for the CO2-induced vasocon-
striction is suggested by the finding that some vascular beds (e.g.
the mesentery) exhibit an acute vasoconstriction in response to
an increase in local CO2 concentration, followed by a later
vasodilator effect (Nielsen et al, 1991; Carr et al, 1993). The acute
vasoconstriction is independent of the endothelium (Carr et al,
1993) and is most likely mediated by an increase in the release of
intracellular calcium in smooth muscle cells (Nielsen et al, 1991).
In tumours, the vasoconstrictive effect of CO2, resulting from
direct action on vascular smooth muscle cells may dominate due
to a defective or deficient endothelium-dependent vasodilatory
mechanism. A similar vasoconstrictive response of tumour vascu-
lature to the endothelium-dependent vasodilator, acetylcholine,
has also been reported (Tozer et al, 1996).
In the study of Hill and co-workers, an endothelium-dependent
vasodilation in normal tissue surrounding the tumours may have
contributed to the observed decrease in tumour blood flow via a
steal effect (Hill et al, 1998). The delay in the decrease in tumour
blood flow may have been attributable to a biphasic response of
the neighbouring vasculature, i.e. an initial vasoconstriction
followed by a more persistent vasodilation. Therefore, the differ-
ence in TBF response to carbogen breathing in the two studies
may be attributable to the sites at which they were growing. In the
window chamber, the tumour was primarily supplied by the arte-
riole which was monitored. On the other hand, the tumour growing
in the hindlimb was most likely supplied by numerous arterioles or
even neovessels, whose flow could be more significantly affected
by changes in the surrounding normal vascular bed.
Theoretical estimation of effects of CO2 breathing on
tumour oxygenation
Secomb and co-workers (1995) have employed a mathematical
model to analyse the effects of oxygen supply and demand on
tumour hypoxic fraction. The Green’s function model calculates
hypoxic fraction based on TBF rate, blood oxygen content, tumour
oxygen consumption rate and vascular geometry. The parameters
used in this mathematical model were based on experimental data
collected from the same experimental model used in the present
study (Secomb et al, 1995; Dewhirst et al, 1996). This model was
used to predict the effects of carbogen breathing on hypoxic frac-
tion, based on the changes in TBF and arterial pO2 observed during
carbogen breathing. The results, which are summarized in Table 3,
clearly depend on the assumptions made in setting up the model,
as already described. However, this model has been found to be
valuable in showing the relative sensitivity of hypoxic fraction to
changes in other parameters (Secomb et al, 1995).
In the control condition utilized in this model, the hypoxic frac-
tion (defined as the proportion of pO2 measurements less than
3 mmHg) is estimated at 34%. When taking into account
that carbogen reduces TBF by 30% and raises arterial pO2 to
450 mmHg, the hypoxic fraction actually increases from 34%
to 37%. Thus, the beneficial effect of increasing blood oxygen
content is entirely negated by the decrease in TBF.
Another effect of carbogen that is often quoted as being impor-
tant for enhancing tumour oxygenation is the Bohr effect, which
predicts that enhanced unloading of oxygen will occur when pCO2
is elevated and blood pH is reduced (Rojas, 1991). In order to
consider this effect in this model, it is important to point out that
prior studies in window chamber models have demonstrated that
intravascular pH is relatively normal, even in regions where inter-
stitial pH is low (Helmlinger et al, 1997). This would suggest that
changes in blood gas pH would likely be reflected in the tumour
microcirculation. If the Bohr effect on the oxygen–haemoglobin
dissociation curve (based on a pH of 7.31 seen in the present
study) is taken into account in this Green’s function model,
carbogen breathing reduces the hypoxic fraction from 34% to
32%. Predictions of tumour hypoxic fraction can also be made
using the best case scenario, i.e. including the increase in arterial
pO2 seen with carbogen breathing, but assuming that TBF is not
reduced. In this case the hypoxic fraction is reduced from 34% to
14%. With the same assumptions the hypoxic fraction drops from
14% to 9% if the Bohr effect is included in the calculation. The
benefit realized from carbogen shifting the oxygen–haemoglobin
dissociation curve does not alter tumour hypoxic fraction to a
degree that would be clinically significant, since a reduction from
34% to 32% represents less than a 10% change in hypoxic frac-
tion. This result suggests that the Bohr effect does not play a major
role in affecting oxygen transport in tumours during carbogen
breathing.
These results are consistent with our prior studies of this tumour
model. Using Eppendorf oximetry we were unable to show a
significant reduction in electrode hypoxic fraction during
carbogen breathing (Brizel et al, 1995). In later studies we were
unable to achieve any prolongation of growth time with carbogen
breathing, relative to room air, after a single radiation dose of
20 Gy (Brizel et al, 1997). In a very recent study, we used micro-
electrodes in subcutaneous tumours to study the temporal course
of oxygenation during carbogen breathing, and again found no
consistent improvement in tumour pO2 (Lanzen et al, 1998).
Implications of CO2 breathing on efficacy of radiation
therapy
The use of carbogen as a radiosensitizer has been studied exten-
sively in both animal and human models. In certain cases carbogen
has been shown to increase tumour pO2, while other studies failed
to demonstrate increased TBF and oxygenation with carbogen
(Song et al, 1987; Mason et al, 1991; Falk et al, 1992; Martin et al,
1993; Teicher et al, 1994; Brizel et al, 1995; Horsman et al, 1995;
Powell et al, 1996, 1997; Hill et al, 1998). In some animal models,
irradiation combined with carbogen breathing has demonstrated
increased survival and growth delay relative to irradiation alone,
while others have failed to demonstrate any benefit (Inch et al,
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Table 3 Green’s function sensitivity study: effect of tumour blood flow,
arterial pO2, and Bohr effect on tumour hypoxic fraction
Blood Arterial PO2 Bohr Hypoxic
Condition flow (%) (mmHg) effect fraction (%)
Control 100 100 No 34
Carbogen 100 450 No 14
Carbogen 100 450 Yes 9
Carbogen 70 450 No 37
Carbogen 70 450 Yes 321970; Martin et al, 1994; Rojas et al, 1996). Despite the above
evidence that carbogen might be effective in reducing tumour
hypoxia, a phase III randomized human trial comparing irradiation
with carbogen to irradiation without carbogen failed to demon-
strate a significant survival benefit or increase in loco-regional
disease control (Rubin, 1979). The reasons for the failure of
carbogen to be a more effective radiosensitizer are unclear. It has
been shown that carbogen’s ability to increase tumour oxygen
supply and radiosensitize is dependent on tissue type, pre-irradia-
tion breathing time and route of administration (Inch et al, 1970;
Siemann et al, 1977; Kallinen et al, 1991; Martin et al, 1993),
suggesting that complex physiologic mechanisms are involved.
The ability of carbogen to radiosensitize more effectively than
100% O2 is reportedly a result of the CO2 component, which is
thought to block hyperoxia-induced vasoconstriction, increase
cardiac output via positive chronotropic effects and shift the
oxygen–haemoglobin dissociation curve to favour the unloading
of oxygen (Kruuv et al, 1996; Rojas, 1991). The results in the
present study contradict the putative mechanisms by which
carbogen is believed to increase tumour oxygen supply. In this
experimental model we have demonstrated that carbogen
breathing causes tumour arteriolar vasoconstriction, resulting in a
25–30% decrease in tumour blood flow. Mathematical models
were employed to estimate the degree to which the Bohr effect
would increase tumour oxygenation while breathing carbogen, and
this contribution was predicted to be minimal. Thus, the decrease
in tumour perfusion far outweighs any benefit gained from the
increased oxygen content of the blood. These results may provide
a potential explanation for the lack of consistent success in clinical
trials utilizing carbogen as a radiosensitizer.
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